1 / 9

Joint Working - Why, When and How?

Joint Working - Why, When and How?. Graham Franklin Regional Business Director, GlaxoSmithKline XXX 10 th November 2009. Ministerial Industry Strategy Group Partnership Working Group

gizela
Télécharger la présentation

Joint Working - Why, When and How?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Joint Working- Why, When and How? Graham Franklin Regional Business Director, GlaxoSmithKline XXX 10th November 2009

  2. Ministerial Industry Strategy Group Partnership Working Group ‘There are a number of areas where increased dialogue and partnership between the NHS and industry would deliver significant benefits for Governments, patients, industry and research’ The evolving environment Feb 08 March 08 June 08 March 09

  3. NHS-ABPI defined Joint Working Defined as situations where, for the benefit of patients, one or more pharmaceutical companies and the NHS pool skills, experience and/or resources for the joint development and implementation of patient-centered projects and share a commitment to successful delivery

  4. How can the NHS and the Pharmaceutical Industry find the mutual benefits of Joint Working? The Pharmaceutical Industry Better patient outcomes

  5. What could a Joint Working Project Look Like? • Pooled resource • Mutual contribution to providing the resources to meet and address the patient need: • Staff training • Staff and or patient education • Economic analysis • Facilitation of pathway redesign • Support for guideline implementation • Funding of project staff requirements (administrative, clinical, analytical health economic and or management resources)

  6. Examples of Partnership Working

  7. NHS Salford Project Win/Win/Win Results Improving COPD ManagementNHS Salford and GSK • Serves more than 216,000 patients • High COPD prevalence (2.5% vs 1.4% national average) • To enhance the group’s capability and capacity to appropriately manage its COPD patient population by implementing: • Treatment pathways and protocol • Health Care Professional and patient education programmes • Patient audit tools (POINTS) • Patient review • Patient: Better outcomes via proactive treatment • NHS: Up-skilled staff, improving quality and resource utilisation • GSK: More opportunities for appropriate use of medicines • Analysis ongoing – interim data indicates: • Length of hospital stay reduced from 7.4 to 6.9 days1 • PCT hospital expenditure reduced by £167,0001 • An estimated 255 hospital admissions were avoided1 • 430 additional patients were added to the COPD register2 1. Data supplied by NHS Salford, 8 June 2009 2. Roberts JA and Diar Bakerly N Benchmarking COPD across an inner city PCT: one year on. Thorax (2008) (Suppl VII): A8 s12 HCM/MTP/09/43726/1, October 2009

  8. Exploring partnership opportunities further • GSK contact: • Graham.c.Franklin@gsk.com – Regional Business Director • David.a.robinson@gsk.com – Area Business Manager • Visit the GSK Stand at London Health ’09 • You can access the Joint Working Toolkit produced by the DH and ABPI on: www.dh.gov.uk

  9. Joint Working- Why, When and How? Graham Franklin Regional Business Director, GlaxoSmithKline XXX 10th November 2009

More Related